BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

9958 related articles for article (PubMed ID: 15663342)

  • 1. Role of imiquimod in skin cancer treatment.
    Urosevic M; Dummer R
    Am J Clin Dermatol; 2004; 5(6):453-8. PubMed ID: 15663342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
    Tillman DK; Carroll MT
    Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical treatment of basal cell carcinoma with the immune response modifier imiquimod.
    Papakostas D; Stockfleth E
    Future Oncol; 2015 Nov; 11(22):2985-90. PubMed ID: 26450707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imiquimod - Its role in the treatment of cutaneous malignancies.
    Bubna AK
    Indian J Pharmacol; 2015; 47(4):354-9. PubMed ID: 26288465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imiquimod and lymphatic field clearance: a new hypothesis based on a remote immune action on skin cancer.
    Akkilic-Materna M; Massone C; Komericki P
    Acta Derm Venereol; 2011 Jun; 91(4):432-5. PubMed ID: 21547348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5% imiquimod cream for the treatment of large superficial basal cell carcinoma.
    Shumack S; Gebauer K; Quirk C; Macdonald K; Walters SA; Owens M
    Arch Dermatol; 2004 Oct; 140(10):1286-7. PubMed ID: 15492202
    [No Abstract]   [Full Text] [Related]  

  • 7. The SINS trial: a randomised controlled trial of excisional surgery versus imiquimod 5% cream for nodular and superficial basal cell carcinoma.
    Ozolins M; Williams HC; Armstrong SJ; Bath-Hextall FJ
    Trials; 2010 Apr; 11():42. PubMed ID: 20409337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of 5% imiquimod cream in treating patients with multiple superficial basal cell carcinomas.
    Marks R; Owens M; Walters SA;
    Arch Dermatol; 2004 Oct; 140(10):1284-5. PubMed ID: 15492200
    [No Abstract]   [Full Text] [Related]  

  • 9. Imiquimod 5 percent cream and the treatment of cutaneous malignancy.
    Navi D; Huntley A
    Dermatol Online J; 2004 Jul; 10(1):4. PubMed ID: 15347486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review.
    Love WE; Bernhard JD; Bordeaux JS
    Arch Dermatol; 2009 Dec; 145(12):1431-8. PubMed ID: 20026854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsyndromic multiple basal cell carcinomas successfully treated with imiquimod 5% cream.
    Kocabaş E; Ermertcan AT; Bilaç C; Bilaç DB; Temiz P
    Cutan Ocul Toxicol; 2010 Dec; 29(4):300-2. PubMed ID: 20684662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical application of imiquimod for the treatment of high-risk facial basal cell carcinoma in Gorlin syndrome.
    Vereecken P; Monsieur E; Petein M; Heenen M
    J Dermatolog Treat; 2004 Apr; 15(2):120-1. PubMed ID: 15204165
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful treatment of two invasive squamous cell carcinomas with topical 5% imiquimod cream in elderly patients.
    Tiodorovic-Zivkovic D; Zalaudek I; Longo C; De Pace B; Albertini G; Argenziano G
    Eur J Dermatol; 2012; 22(4):579-80. PubMed ID: 22652500
    [No Abstract]   [Full Text] [Related]  

  • 14. Case study: Imiquimod 5% cream in the treatment of a large nodular basal cell carcinoma.
    Shulstad RM
    Dermatol Nurs; 2009; 21(2):86-7. PubMed ID: 19507375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of internal melanoma metastases following application of topical imiquimod to overlying skin.
    Miller AK; Dusing R; Meggison A; Aires D
    J Drugs Dermatol; 2011 Mar; 10(3):302-5. PubMed ID: 21369648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of malignant melanoma in situ with topical 5% imiquimod cream.
    Ray CM; Kluk M; Grin CM; Grant-Kels JM
    Int J Dermatol; 2005 May; 44(5):428-34. PubMed ID: 15869545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Has imiquimod 5% cream a role in the management of recurrent basal cell carcinoma?
    RUIZ-VILLAVERDE R; SANCHEZ-CANO D; BURKHARDT-PEREZ P; SINTES RN
    Eur J Dermatol; 2009; 19(5):481-3. PubMed ID: 19527989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of invasive squamous cell carcinoma with 5-percent imiquimod cream.
    Konstantopoulou M; Lord MG; Macfarlane AW
    Dermatol Online J; 2006 Mar; 12(3):10. PubMed ID: 16638424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of persistent melanoma in situ with 5% imiquimod cream.
    Muñoz CM; Sánchez JL; Martín-García RF
    Dermatol Surg; 2004 Dec; 30(12 Pt 2):1543-5. PubMed ID: 15606836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of various types of basal cell carcinoma with topical 5% imiquimod in the elderly who refused surgical intervention: a case series.
    Kaçar SD; Özuğuz P; Erkan F; Karaca Ş
    J Dermatolog Treat; 2015 Apr; 26(2):165-7. PubMed ID: 24731081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 498.